<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04591587</url>
  </required_header>
  <id_info>
    <org_study_id>EyeHPristina</org_study_id>
    <nct_id>NCT04591587</nct_id>
  </id_info>
  <brief_title>Corneal Lenticule Implantation in Keratoconus Disease With Relex Smile Surgery</brief_title>
  <official_title>Corneal Lenticule Implantation in Keratoconus Disease With Relex Smile Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Faruk Semiz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eye Hospital Pristina Kosovo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      CORNEAL LENTICULE IMPLANTATION IN KERATOCONUS DISEASE WITH RELEX SMILE SURGERY&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Purpose:&#xD;
&#xD;
      The purpose of our study is to investigate the feasibility and effect of fresh lenticule&#xD;
      implantation as allogenic graft that will be taken from myopic patients, in order to implant&#xD;
      in patients with keratocouns disease using VisuMax Femtosecond laser - Smile module surgery&#xD;
      which primary objective in to increase central corneal thickness and secondary objective is&#xD;
      to improve visual acuity and reducing K-values.&#xD;
&#xD;
      Methods:&#xD;
&#xD;
      All the patients were clinically diagnosed with progressive keratoconus. Twenty (20) patients&#xD;
      underwent SMILE surgery (first group), and twenty (20) patients underwent lenticule&#xD;
      implantation (second group). Visual acuity, corneal topography, electron microscop,anterior&#xD;
      segment optical coherence tomography, were analyzed.&#xD;
&#xD;
      Outcome:&#xD;
&#xD;
      Central corneal thickness were improved at the same day of surgery and vision started to&#xD;
      improve at first week postoperatively in the second group (lenticule implant group). Corneal&#xD;
      topography showed a statistically significant decrease in the anterior K1 and K2. All the&#xD;
      grafts from both groups were clearly visible by anterior segment optical coherence tomography&#xD;
      observation and electron microscope. The central corneal thickness was stable during the&#xD;
      6-month study period. No complications were observed during short term follow-up.&#xD;
&#xD;
      Opinion:&#xD;
&#xD;
      In our opinion, the present study may suggest that this procedure, using fresh lenticule with&#xD;
      stromal stem cells and live keratocites is safe, reliable, and effectively increases corneal&#xD;
      thickness and improves visual acuity with no adverse effects, which may provide new avenues&#xD;
      in the treatment of corneal ectasia.&#xD;
&#xD;
      Key Words:&#xD;
&#xD;
      keratoconus,small incision,fresh lenticule, stromal implantation,stromal stem cells, Smile&#xD;
      surgery&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">June 15, 2024</completion_date>
  <primary_completion_date type="Actual">January 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Both models participated in this study. Model ages were from 20 up to 45</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Increase of corneal thickness at patients Lenticule group</measure>
    <time_frame>12 months</time_frame>
    <description>Increase of corneal central thickness using fresh lenticule with stromal stem cells and live keratocytes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement of visual acuity at patients Lenticule group</measure>
    <time_frame>12 months</time_frame>
    <description>Increase of visual acuity using fresh lenticule, decrease of astigmatism and increase of corneal thickness</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Keratoconus</condition>
  <arm_group>
    <arm_group_label>Smile Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Twenty patients (20) underwent SMILE surgery (first group)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lenticule Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Twenty patients (20) underwent lenticule implantation (second group)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lenticule Implantation in Keratoconus Disease with RELEX Smile Surgery</intervention_name>
    <description>Lenticule Implantation in Keratoconus Disease with RELEX Smile Surgery using VisuMax Femtosecond laser- Smile module surgery with primary objective to increase central corneal thickness and secondary objective to improve visual acuity and reduces K-values</description>
    <arm_group_label>Lenticule Group</arm_group_label>
    <arm_group_label>Smile Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients clinically diagnosed with progressive keratoconus&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Active anterior segment pathologic features, Corneal thickness over 420, Previous&#xD;
             corneal or anterior segment surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Eye Hospital Pristina</name>
      <address>
        <city>Pristina</city>
        <zip>10000</zip>
        <country>Kosovo</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Kosovo</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>June 15, 2020</study_first_submitted>
  <study_first_submitted_qc>October 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2020</study_first_posted>
  <last_update_submitted>August 18, 2021</last_update_submitted>
  <last_update_submitted_qc>August 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Eye Hospital Pristina Kosovo</investigator_affiliation>
    <investigator_full_name>Dr. Faruk Semiz</investigator_full_name>
    <investigator_title>Principal Doctor</investigator_title>
  </responsible_party>
  <keyword>Keratoconus</keyword>
  <keyword>Small Incision</keyword>
  <keyword>Fresh Lenticule</keyword>
  <keyword>Stromal Implantation</keyword>
  <keyword>Stromal Stem Cells</keyword>
  <keyword>Smile Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>June 15, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/87/NCT04591587/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

